A citation-based method for searching scientific literature


List of co-cited articles
64 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
27

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
21

Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
16

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
14

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
11

Quantifying heterogeneity in a meta-analysis.
Julian P T Higgins, Simon G Thompson. Stat Med 2002
11

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
11


The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
9

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
9

Practical methods for incorporating summary time-to-event data into meta-analysis.
Jayne F Tierney, Lesley A Stewart, Davina Ghersi, Sarah Burdett, Matthew R Sydes. Trials 2007
8

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
6

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
5

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer, David Moher, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. BMJ 2015
5

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
4


Metaprop: a Stata command to perform meta-analysis of binomial data.
Victoria N Nyaga, Marc Arbyn, Marc Aerts. Arch Public Health 2014
845
4

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
4

Global cancer statistics, 2012.
Lindsey A Torre, Freddie Bray, Rebecca L Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, Ahmedin Jemal. CA Cancer J Clin 2015
3

Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software.
Nicola Orsini, Ruifeng Li, Alicja Wolk, Polyna Khudyakov, Donna Spiegelman. Am J Epidemiol 2012
782
3

Estimating the mean and variance from the median, range, and the size of a sample.
Stela Pudar Hozo, Benjamin Djulbegovic, Iztok Hozo. BMC Med Res Methodol 2005
3





Meta-analysis in clinical trials revisited.
Rebecca DerSimonian, Nan Laird. Contemp Clin Trials 2015
940
3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. J Clin Epidemiol 2009
3

Cancer statistics in China, 2015.
Wanqing Chen, Rongshou Zheng, Peter D Baade, Siwei Zhang, Hongmei Zeng, Freddie Bray, Ahmedin Jemal, Xue Qin Yu, Jie He. CA Cancer J Clin 2016
2

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
2

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Open Med 2009
2


Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.
Chuan Qin, Luoqi Zhou, Ziwei Hu, Shuoqi Zhang, Sheng Yang, Yu Tao, Cuihong Xie, Ke Ma, Ke Shang, Wei Wang,[...]. Clin Infect Dis 2020
2

An interleukin-10 gene polymorphism associated with the development of cervical lesions in women infected with Human Papillomavirus and using oral contraceptives.
Bárbara Simas Chagas, Ana Pavla Almeida Diniz Gurgel, Heidi Lacerda Alves da Cruz, Carolina Maria Medeiros Amaral, Marcus Vinicius Cardoso, Jacinto da Costa Silva Neto, Luiz Antônio Ferreira da Silva, Eugênia Maria Bezerra de Albuquerque, Maria Tereza Cartaxo Muniz, Antonio Carlos de Freitas. Infect Genet Evol 2013
19
10

Mapping of the human IL10 gene and further characterization of the 5' flanking sequence.
J Eskdale, D Kube, H Tesch, G Gallagher. Immunogenetics 1997
279
2


Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice.
Julian Higgins, Simon Thompson, Jonathan Deeks, Douglas Altman. J Health Serv Res Policy 2002
380
2

Assessing heterogeneity in meta-analysis: Q statistic or I2 index?
Tania B Huedo-Medina, Julio Sánchez-Meca, Fulgencio Marín-Martínez, Juan Botella. Psychol Methods 2006
2

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, Jie Xiang, Yeming Wang, Bin Song, Xiaoying Gu,[...]. Lancet 2020
2

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
2


Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.
Christina Fitzmaurice, Degu Abate, Naghmeh Abbasi, Hedayat Abbastabar, Foad Abd-Allah, Omar Abdel-Rahman, Ahmed Abdelalim, Amir Abdoli, Ibrahim Abdollahpour, Abdishakur S M Abdulle,[...]. JAMA Oncol 2019
584
2


Suicidal Ideation, Attempt, and Determining Factors among HIV/AIDS Patients, Ethiopia.
Huluagresh Bitew, Gashaw Andargie, Agitu Tadesse, Amsalu Belete, Wubalem Fekadu, Tesfa Mekonen. Depress Res Treat 2016
31
6



A quality-effects model for meta-analysis.
Suhail A R Doi, Lukman Thalib. Epidemiology 2008
146
2

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Int J Surg 2010
2

Cancer-related inflammation and treatment effectiveness.
Connie I Diakos, Kellie A Charles, Donald C McMillan, Stephen J Clarke. Lancet Oncol 2014
773
2

Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.
Christopher P Neal, Vaux Cairns, Michael J Jones, Muhammad M Masood, Gael R Nana, Christopher D Mann, Giuseppe Garcea, Ashley R Dennison. Med Oncol 2015
63
3

Inflammation and cancer: back to Virchow?
F Balkwill, A Mantovani. Lancet 2001
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.